Immutep (IMMP) EBT (2012 - 2024)
Immutep's (IMMP) quarterly EBT came in at -$17.3 million in Q4 2024, down 14.74% YoY from -$20.3 million in Q1 2024, and up 43.7% on a QoQ basis from -$30.7 million in Q2 2024.
Immutep (IMMP) EBT (2012 - 2024) Analysis & Trends
Immutep (IMMP) has 10 years of EBT data on file, last reported at -$17.3 million in Q4 2024.
- Quarterly EBT fell 14.74% year-over-year to -$17.3 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$77.1 million (down 67.05% YoY) and the FY2025 annual result came in at -$39.3 million, down 35.26% from the prior year.
- EBT climbed to -$17.3 million in Q4 2024, from -$30.7 million in the prior quarter.
- In the past five years, EBT ranged from a high of -$12.3 million in Q4 2021 to a low of -$30.7 million in Q2 2024.
- A 4-year average of -$17.9 million and a median of -$15.1 million in 2023 frame the typical range for EBT.
- Annual changes were most pronounced in 2023 — EBT declined 6.9% — and 2024, when it dropped 14.74%.
- Tracing IMMP's EBT over 4 years: stood at -$12.3 million in 2021, then declined by 14.73% to -$14.1 million in 2022, then slipped by 6.9% to -$15.1 million in 2023, then dropped by 14.74% to -$17.3 million in 2024.
- The last three EBT figures came in at -$17.3 million (Q4 2024), -$30.7 million (Q2 2024), and -$15.1 million (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.47 Bn | 131.61 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 86.36 Bn | 78.37 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 65.16 Bn | 59.98 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 58.99 Bn | 53.85 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 31.74 Bn | 28.43 Bn | 992.69 Mn | 177.81 Mn |
| 7 | BioNTech SE | 28.01 Bn | 9.61 Bn | 668.28 Mn | -264.70 Mn |
| 8 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn | -11.37 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - | 81.49 Mn |
| 10 | Immutep | 55.93 Mn | -9.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -17.28 Mn |
| Jun 30, 2024 | -30.68 Mn |
| Dec 31, 2023 | -15.06 Mn |
| Dec 31, 2022 | -14.08 Mn |
| Dec 31, 2021 | -12.28 Mn |
| Dec 31, 2019 | -4.74 Mn |
| Jun 30, 2019 | -14.15 Mn |
| Dec 31, 2018 | -7.17 Mn |
| Jun 30, 2017 | -1.99 Mn |
| Mar 31, 2017 | -1.80 Mn |
| Dec 31, 2016 | -3.51 Mn |
| Jun 30, 2016 | -1.77 Mn |
| Mar 31, 2016 | -1.99 Mn |
| Jun 30, 2015 | -4.98 Bn |
| Dec 31, 2012 | -8.27 Mn |